Scholarly Index
Victoria M. Richon
Ribon Therapeutics (United States); 31,196 total citations; 158 total publications; best world rank #56
Ribon Therapeutics (United States)
31,196Total citations
158Total publications
76H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Histone Deacetylase Inhibitors Research | Lifetime | 56 | US 40 | 99.31 |
| Protein Degradation and Inhibitors | Lifetime | 91 | US 53 | 99.17 |
| Epigenetics and DNA Methylation | Lifetime | 443 | US 246 | 98.85 |
| Peptidase Inhibition and Analysis | Lifetime | 334 | US 154 | 98.68 |
| Ubiquitin and proteasome pathways | Lifetime | 555 | US 278 | 97.62 |
| Cancer-related gene regulation | Lifetime | 563 | US 262 | 97.39 |